Literature DB >> 15860430

Current progress in the use of traditional medicines and nutraceuticals.

Stephen Barnes1, Jeevan Prasain.   

Abstract

Traditional medicines in the form of botanical dietary supplements and nutraceuticals have found a place in 21st century healthcare. They nonetheless all contain compounds that are foreign to humans (i.e. xenobiotics) and that are subject to the same pharmacological issues encountered by synthetic therapeutic agents. It is crucial therefore for all parties, the medical profession, investigative scientists, the regulatory agencies and the public, to understand the particular characteristics of botanicals and nutraceuticals and their potential for success and failure in preventing and confronting disease.

Entities:  

Mesh:

Year:  2005        PMID: 15860430     DOI: 10.1016/j.pbi.2005.03.010

Source DB:  PubMed          Journal:  Curr Opin Plant Biol        ISSN: 1369-5266            Impact factor:   7.834


  8 in total

Review 1.  Botanicals for age-related diseases: from field to practice.

Authors:  Connie M Weaver; Stephen Barnes; J Michael Wyss; Helen Kim; Dorothy M Morré; D James Morré; James E Simon; Mary Ann Lila; Elsa M Janle; Mario G Ferruzzi
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

Review 2.  Technologies and experimental approaches at the National Institutes of Health Botanical Research Centers.

Authors:  Stephen Barnes; Diane F Birt; Barrie R Cassileth; William T Cefalu; Floyd H Chilton; Norman R Farnsworth; Ilya Raskin; Richard B van Breemen; Connie M Weaver
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

3.  Research Highlights from the Purdue-UAB Botanicals Research Center for Age Related Diseases.

Authors:  Connie M Weaver; Stephen Barnes; J Michael Wyss; Helen Kim; Dorothy M Morré; D James Morré; James E Simon; Mary Ann Lila; Elsa M Janle; Mario G Ferruzzi
Journal:  Pharm Biol       Date:  2009-08-01       Impact factor: 3.503

4.  Assessing the regioselectivity of OleD-catalyzed glycosylation with a diverse set of acceptors.

Authors:  Maoquan Zhou; Adel Hamza; Chang-Guo Zhan; Jon S Thorson
Journal:  J Nat Prod       Date:  2013-01-29       Impact factor: 4.050

5.  Insights into the molecular mechanisms of the anti-atherogenic actions of flavonoids in normal and obese mice.

Authors:  Elena V Shabrova; Olga Tarnopolsky; Ajay P Singh; Jorge Plutzky; Nicholi Vorsa; Loredana Quadro
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

6.  Molecular dissection of pathway components unravel atisine biosynthesis in a non-toxic Aconitum species, A. heterophyllum Wall.

Authors:  Varun Kumar; Nikhil Malhotra; Tarun Pal; Rajinder Singh Chauhan
Journal:  3 Biotech       Date:  2016-04-18       Impact factor: 2.406

7.  Growth inhibition and apoptosis induction by (+)-Cyanidan-3-ol in hepatocellular carcinoma.

Authors:  Jitender Monga; Saurabh Pandit; Rajinder Singh Chauhan; Chetan Singh Chauhan; Shailender Singh Chauhan; Manu Sharma
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

Review 8.  Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids.

Authors:  Mohammed Kawser Hossain; Ahmed Abdal Dayem; Jihae Han; Yingfu Yin; Kyeongseok Kim; Subbroto Kumar Saha; Gwang-Mo Yang; Hye Yeon Choi; Ssang-Goo Cho
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.